Evidence map›Paper›PMID 35155218›Full record

ArticleFrontiers in oncology2021

CA9-Related Acidic Microenvironment Mediates CD8+ T Cell Related Immunosuppression in Pancreatic Cancer.

Lingdi Yin, Yichao Lu, Cheng Cao, Zipeng Lu, Jishu Wei, Xiaole Zhu, Jianmin Chen, Feng Guo, Min Tu, Chunhua Xi and 7 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 27 citations in OpenAlex.

  1. Dual-tracer PET/CT with [European journal of nuclear medicine and molecular imaging · 2026
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 1 country.

Lingdi YinPancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Yichao LuPancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Cheng CaoPancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zipeng LuPancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Jishu WeiPancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Xiaole ZhuPancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Jianmin ChenPancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Feng GuoPancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Min TuPancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Chunhua XiPancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Kai ZhangPancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Junli WuPancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Wentao GaoPancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Kuirong JiangPancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Yi MiaoPancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Qiang LiPancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Yunpeng PengPancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Jiangsu Province Hospital · CNNanjing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study aims to integrate pancreatic cancer TCGA, GEO, and single-cell RNA-sequencing (scRNA-seq) datasets, and explore the potential prognostic markers and underlying mechanisms of the immune microenvironment of pancreatic cancer through bioinformatics methods,

methodsExpression data and clinicopathological data of pancreatic cancer TCGA, GEO (GSE131050), single cell sequencing (PAAD_CRA001160) dataset were downloaded. We used R/Bioconductor edgeR for differential expression analysis. ClusterProfiler was utilized to perform GO enrichment analysis on differentially expressed genes. The online software CIBERSORT was used to reanalyze the mRNA expression data of pancreatic cancer. CellRanger, RunPCA, FindNeighbors, FindClusters, RunTSNE and RunUMAP were used to perform preprocessing, cell clustering and expression profile analysis on single-cell sequencing data sets. We analyzed intracellular pH with or without CA9 inhibitor SLC-0111. Indirect co-culture model of human pancreatic cancer cell lines and healthy individual-derived PBMCs were used to determine the effect of CA9-related Acidic Microenvironment on CD8+ T cells.

resultsThe CIBERSORT analysis of TCGA pancreatic cancer transcriptome sequencing data showed that among the 22 immune microenvironment components, CD8+ T cell infiltration was significantly correlated with the prognosis of pancreatic cancer patients. The differential expression analysis of the TCGA data grouped by the level of CD8+ T cell infiltration indicates that the expression of carbonic anhydrase 9 (CA9) is the most significant, and the survival analysis suggests that CA9 is associated with the overall survival of pancreatic cancer. TCGA data and GEO data set GSE131050 expression correlation analysis suggests that CA9 and CD8 expression are closely related. Pancreatic cancer single-cell sequencing data set PAAD_CRA001160 analysis results show that CA9 is mainly expressed in pancreatic cancer cell clusters, and the expression of the cancer cell subgroup CA9 in the single-cell data set is correlated with CD8+ T cell infiltration.

conclusionPancreatic cancer cells may inhibit the infiltration of CD8+ T cells through CA9. Further exploration of its related mechanisms can be used to explore the immune escape pathway of pancreatic cancer and provides new perspectives immune targeted therapy.

Indexed as

CA9CD8+ T cellsimmunotherapypancreatic cancertumor microenvironment

Identifiers

PMID35155218
PMCPMC8828571
OpenAlexW4210607871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.